Qlaris Bio
Series B
Therapy for ophthalmic diseases
Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.
Founders
B
LinkedIn
Similar Startups
OpenEvidence
Series D
Organizing the world’s medical knowledge
Centivax
Broad-spectrum vaccine
Latent
Series A
Medical language models for healthcare overhead
Celularity
Biotech cellular medicines
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Freenome
Blood test to detect colorectal cancer